Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S4W-22404 · Session 4

Further to the answer to question S4T-00763 by Michael Matheson on 12 August 2014 (Official Report, c. 33250), what the outcome was of the …

Answered Asked by Jackson Carlaw Con Lodged 19 Aug 2014

The question

To ask the Scottish Government, further to the answer to question S4T-00763 by Michael Matheson on 12 August 2014 (Official Report, c. 33250), what the outcome was of the minister’s meeting with Health Protection Scotland to discuss the Ebola virus, and how the World Health Organization’s approval for the use of experimental drugs to combat the outbreak in west Africa will impact on contingency planning in Scotland.

The answer

Answered by Michael Matheson on 4 Sep 2014 · 16 days after it was lodged, on time

I met with Heath Protection Scotland (HPS) on 19 August 2014 to discuss Scotland’s preparedness for any possible cases of Ebola virus. HPS reported the risk to the people of Scotland remains very low and the NHS stands ready to respond to any suspected cases, by following well-established protocols for dealing with highly infectious diseases.
In addition and following that meeting, a short life working group has been established to bring together the Scottish Government and relevant Scottish agencies to ensure we continue to monitor this situation and to consider what more needs to be done.
The World Health Organization approval and proposed use of experimental drugs to treat Ebola could reduce the number of patients infected and help reduce spread of the virus. There are however limited supplies of Zmapp globally and so the impact of the drug is likely to be limited and does not impact directly on contingency planning within Scotland.

In the Official Report

No contribution in the Official Report cites S4W-22404 by reference.